Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Resat Cinar

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Journal of Medicinal Chemistry|August 23, 2023
Cannabinoformins: Designing Biguanide-Embedded, Orally Available, Peripherally Selective Cannabinoid-1 Receptor Antagonists for Metabolic Syndrome DisordersSzabolcs Dvorácskó, Alexa Herrerias, Anna Oliverio, et al.
Molecular Metabolism|November 7, 2017
Decreasing CB<sub>1</sub> receptor signaling in Kupffer cells improves insulin sensitivity in obese miceTony Jourdan, Sarah M Nicoloro, Zhou Zhou, et al.
Scientific Reports|October 13, 2015
Mice lacking GPR3 receptors display late-onset obese phenotype due to impaired thermogenic function in brown adipose tissueGrzegorz Godlewski, Tony Jourdan, Gergő Szanda, et al.
Molecules (Basel, Switzerland)|August 27, 2021
Effects of a Peripherally Restricted Hybrid Inhibitor of CB1 Receptors and iNOS on Alcohol Drinking Behavior and Alcohol-Induced EndotoxemiaLuis Santos-Molina, Alexa Herrerias, Charles N Zawatsky, et al.
American Journal of Respiratory Cell and Molecular Biology|August 18, 2019
Bleomycin Induces Drug Efflux in Lungs. A Pitfall for Pharmacological Studies of Pulmonary FibrosisJoshua K Park, Nathan J Coffey, Steven P Bodine, et al.
The American Journal of the Medical Sciences|June 6, 2025
Elevated blood anandamide levels in acute COVID-19 pneumonia with respiratory failureAbhishek Basu, Lenny Pommerolle, Muhammad Arif, et al.
Journal of Medicinal Chemistry|January 27, 2022
Synthesis, Biological Evaluation, and Molecular Modeling Studies of 3,4-Diarylpyrazoline Series of Compounds as Potent, Nonbrain Penetrant Antagonists of Cannabinoid-1 (CB<sub>1</sub>R) Receptor with Reduced LipophilicityMalliga R Iyer, Resat Cinar, Casey M Wood, et al.
Regulatory Toxicology and Pharmacology : RTP|October 4, 2019
Preclinical toxicity evaluation of JD5037, a peripherally restricted CB<sub>1</sub> receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitisVijay Pralhad Kale, Seth Gibbs, John A Taylor, et al.
Nature Medicine|August 20, 2013
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetesTony Jourdan, Grzegorz Godlewski, Resat Cinar, et al.
Diabetes|January 14, 2017
Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type 2 DiabetesTony Jourdan, Gergő Szanda, Resat Cinar, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|August 23, 2023
Cannabinoformins: Designing Biguanide-Embedded, Orally Available, Peripherally Selective Cannabinoid-1 Receptor Antagonists for Metabolic Syndrome DisordersSzabolcs Dvorácskó, Alexa Herrerias, Anna Oliverio, et al.
Molecular Metabolism|November 7, 2017
Decreasing CB<sub>1</sub> receptor signaling in Kupffer cells improves insulin sensitivity in obese miceTony Jourdan, Sarah M Nicoloro, Zhou Zhou, et al.
Scientific Reports|October 13, 2015
Mice lacking GPR3 receptors display late-onset obese phenotype due to impaired thermogenic function in brown adipose tissueGrzegorz Godlewski, Tony Jourdan, Gergő Szanda, et al.
Molecules (Basel, Switzerland)|August 27, 2021
Effects of a Peripherally Restricted Hybrid Inhibitor of CB1 Receptors and iNOS on Alcohol Drinking Behavior and Alcohol-Induced EndotoxemiaLuis Santos-Molina, Alexa Herrerias, Charles N Zawatsky, et al.
American Journal of Respiratory Cell and Molecular Biology|August 18, 2019
Bleomycin Induces Drug Efflux in Lungs. A Pitfall for Pharmacological Studies of Pulmonary FibrosisJoshua K Park, Nathan J Coffey, Steven P Bodine, et al.
The American Journal of the Medical Sciences|June 6, 2025
Elevated blood anandamide levels in acute COVID-19 pneumonia with respiratory failureAbhishek Basu, Lenny Pommerolle, Muhammad Arif, et al.
Journal of Medicinal Chemistry|January 27, 2022
Synthesis, Biological Evaluation, and Molecular Modeling Studies of 3,4-Diarylpyrazoline Series of Compounds as Potent, Nonbrain Penetrant Antagonists of Cannabinoid-1 (CB<sub>1</sub>R) Receptor with Reduced LipophilicityMalliga R Iyer, Resat Cinar, Casey M Wood, et al.
Regulatory Toxicology and Pharmacology : RTP|October 4, 2019
Preclinical toxicity evaluation of JD5037, a peripherally restricted CB<sub>1</sub> receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitisVijay Pralhad Kale, Seth Gibbs, John A Taylor, et al.
Nature Medicine|August 20, 2013
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetesTony Jourdan, Grzegorz Godlewski, Resat Cinar, et al.
Diabetes|January 14, 2017
Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type 2 DiabetesTony Jourdan, Gergő Szanda, Resat Cinar, et al.
Pageof 10